BIOX
BIOX
NASDAQ · Chemicals

Bioceres Crop Solutions Corp

$0.41
-0.04 (-9.33%)
As of May 16, 2:23 AM ET ·
Financial Highlights (FY 2026)
Revenue
349.69M
Net Income
-58,137,135
Gross Margin
39.0%
Profit Margin
-16.6%
Rev Growth
+0.5%
D/E Ratio
1.04
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.0% 39.0% 35.4% 35.4%
Operating Margin -0.7% -0.6% 15.8% 13.1%
Profit Margin -16.6% -15.8% 12.8% 14.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 349.69M 347.98M 10.13M 10.46M
Gross Profit 136.31M 135.64M 3.59M 3.71M
Operating Income -2,342,890 -2,098,319 1.61M 1.37M
Net Income -58,137,135 -52,068,286 1.30M 1.47M
Gross Margin 39.0% 39.0% 35.4% 35.4%
Operating Margin -0.7% -0.6% 15.8% 13.1%
Profit Margin -16.6% -15.8% 12.8% 14.0%
Rev Growth +0.5% +0.5% +24.0% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.92M 6.92M 7.53M 9.76M
Total Equity 6.64M 6.64M 24.77M 27.77M
D/E Ratio 1.04 1.04 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -10,043,316 -9,494,626 2.20M 2.21M
Free Cash Flow 1.19M 1.17M